Pfizer will soon publish the figures for the past quarter – the expert forecasts.
Pfizer will present the figures for the most recent quarter, which ended on March 31, 2026, at the financial conference on May 5, 2026.
On average, 20 analysts expect earnings per share of USD 0.722. In the same quarter last year, earnings per share were $0.520.
The estimates of 18 analysts assume an average of USD 13.84 billion in sales for the past quarter – which would correspond to an increase of 0.91 percent compared to the same quarter of the previous year, in which USD 13.72 billion was on the books.
Forecasts from 26 analysts for the current fiscal year are for average earnings per share of $2.96, compared to $1.36 per share last year. In terms of annual sales, 24 analysts expect an average of USD 61.38 billion compared to USD 62.58 billion in the previous year.
Editorial team finanzen.net
By the way: Pfizer and other US stocks can even be traded on finanzen.net ZERO until 11 p.m. (without order fees, plus spreads). Open a depot now for free and secure a new customer bonus!
Selected leveraged products on Pfizer
With knock-outs, speculative investors can participate disproportionately in price movements. Simply select the lever you want and we will show you suitable open-end products on Pfizer
The leverage must be between 2 and 20
Advertising
